Update on Outbreak of Paralysis in US: Acute Flaccid Myelitis
October 16, 2014
LISTEN & SUBSCRIBE ON ITUNES
DOWNLOAD MP3
About Our Guest Speakers
Benjamin M. Greenberg, MD, MHS
Associate Professor at UT Southwestern Medical Center, Director of the Transverse Myelitis and Neuromyelitis Optica Program, Dallas, TX
Associate Professor at UT Southwestern Medical Center, Deputy Director of the Multiple Sclerosis Program and Director of the Transverse Myelitis and Neuromyelitis Optica Program, Dallas, TX
Dr. Benjamin Greenberg received his Bachelor of Arts degree from Johns Hopkins University and his Masters Degree in Molecular Microbiology and Immunology from the Johns Hopkins School of Public Health in Baltimore, Maryland. He attended medical school at Baylor College of Medicine in Houston, Texas. Then, he completed an internship in medicine at Rush Presbyterian-St. Lukes Medical Center in Chicago, Illinois before going on to his residency in neurology at The Johns Hopkins Hospital in Baltimore, MD. He then joined the faculty within the division of neuroimmunology at Hopkins and became the co-director of the Transverse Myelitis Center and director of the Encephalitis Center. In January of 2009 he was recruited to the faculty at the University of Texas Southwestern Medical Center where he was named Deputy Director of the Multiple Sclerosis Program and Director of the new Transverse Myelitis and Neuromyelitis Optica Program. That same year he established the Pediatric Demyelinating Disease Program at Children’s Medical Center Dallas.
Dr. Greenberg is recognized internationally as an expert in rare autoimmune disorders of the central nervous system (e.g. transverse myelitis, neuromyelitis optica, ADEM and autoimmune encephalitis). He splits his clinical time between seeing both adult and pediatric patients. He routinely consults on the inpatient units of University Hospital, Zale Lipshy, Parkland and Children’s. His research interests are in both the diagnosis and treatment of transverse myelitis, neuromyelitis optica, encephalitis, multiples sclerosis and infections of the nervous system. He is actively involved in developing better ways to diagnose and prognosticate for patients with these disorders. He has led an effort to improve biorepository development and has created uniform protocols for sample handling and analysis. As part of this initiative his research has identified novel biomarkers that may be able to distinguish between patients with various neurologic disorders. He also coordinates trials that study new treatments to prevent neurologic damage and restore function to those who have already been affected. He currently serves as the Director of the Neurosciences Clinical Research Center and is a Cain-Denius Foundation Scholar.
Teri Schreiner, MD, MPH
Assistant Professor of Neurology and Pediatrics at University of Colorado School of Medicine and Children’s Hospital Colorado
Dr. Teri Schreiner is a neuroimmunology specialist at the University of Colorado and pediatric neurologist at Children’s Hospital Colorado. She is sub-specialized in pediatric onset demyelinating disorders of the central nervous system and has begun a multi-disciplinary clinic for children with these disorders. Dr. Schreiner sees patients at both the Rocky Mountain MS Center at the Anschutz Pavilion of the University of Colorado and at Children’s Hospital Colorado. Her areas of interest include immune-mediated neurologic disease, quality of life in pediatric patients with demyelinating disease, biomarkers of multiple sclerosis and participation in clinical trials. Dr. Schreiner has a Master’s degree in health policy and administration. She worked in health care consulting for several years prior to her career in medicine.
